A comparative study between the efficacy of 35% glycolic acid peel and triple combination cream in the treatment of melasma

References

1. Balakrishnan .R, Mc Michael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S; Development and validation of a health related quality of life instrument for women with melasma; Br J Dermatol 2003;149:572-7.
2. Pawasker M, Parikh P, Marswoski T, McMichael AJ, Feldman SR, Balakrishnan R; Melasma and its impact on health related quality of life in Hispanics women. J Dermatol 2007;18:5-9.
3. Cestari T, Hexsel D, Viegas M, Azulay L, Hassun K, Almeida AR; Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the melasQol-BP study and improvement of Qol of melasma patients after triple combination therapy; Br J Dermatol 2007;156:13-20.
4. Katsambas A, Antoniou C; Melasma: Classification and Treatment. J European Academy Dermatology and venereology 1995;4:217-223.
5. Stulberg DL, Clark N; Common hyperpigmentation disorders in Adults; Part II; Melanoma, Seborrheic Keratoses, Acanthosis Nigricans, Melasma, Diabetic Dermopathy, Tinea Versicolor and Post inflammatory Hyperpigmentation. Am Fam Phya 2003;68:1963-8.
6. Balakrishnan R; Predictors of Health Related Quality of Life in Women with Melasma; Cosmetic Dermatol 2003;16:25-30.
7. Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P; A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma; J Eur Acad Dermatol Venerol 2009;23:1254-
8. Rendon MI; Utilizing combination therapy to optimize melasma outcomes; J Drugs Dermatol 2004;3(S):27-34.
9. Grimes PE; Melasma: etiologic and therapeutic considerations; arch Dermatol 1995;131:1453-7.
10. Vazquez M, Maldonaldo H, Benaman C, Sanchez JL; Melasma in men: A clinical and histologic study; Int. J Dermatol 1988;27:25-7.
11. Nanda S, Grover C, SN Reddy B; Efficacy of hydroquinone (2%) versus Tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma; Dermatol Surg 2004; 30:3-386.
12. Pasricha JS, Khaitan BK, Dash S; Pigmentary disorders in India; Dermatol Clin 2007;25:343-522.
13. Victor FC, Gelber J, Rao B; Melasma : A Review J Cutan Med Surg 2004;8:97-102.
14. Sanchez NP, Pathak MA, Satos S, Fitzpatrick TB, Sanchez JL, Mihm Jr MC; Melasma: A clinical, light microscopic, ultrastructural and immunofluorescence study; J Am Acad of Dermatol 1981;46:698-710.
15. Hann SK, Im S, Chung WS, Kim do Y; Pigmentary disorders in the South East; Dermatol Clin 2007;25:431-
16. Hughes BR; Melasma occurring in twin sisters; J Am Acad Dermatol, 1987;17:841.
17. Resnick S; Melasma induced by oral contraceptive drugs; J Am Med Assoc.1967;199:95-9.
18. Pandya AG, Guevara IL; Disordes of hyperpigmentation; Dermatol clin 2000;181:91-8.
19. Perez M, Sanchez JL, Aguilo F; Endocrinologic profile of patients with idiopathic melasma; J Invest Dermatol 1983;81:543-5.
20. Sialy R, Hassan I, Kaur I, Dash RJ,; Melasma in men : A hormonl profile; J Dermatol 2000;27:64-5.
21. Lutfi RJ, Fridmanis M, Misrunas AL; Association of melasma with thyroid autoimmunity and other thyroid abnormalities and their relationship to the origin of melisma; J Clin Endocrinol Metab 1985;61:28-31.
22. Piamphongsant T; Treatment of melasma: A review with personal experience; Int J Dermatol 1998;37:897-903.
23. Gano SE, Garcia RL; Topical tretinoin, hydroquinone and betamethasone valerate in the therapy of melasma; Cutis 1979;23:239-41. Ameen Basil et al. A comparative study between the efficacy of 35% glycolic acid peel and triple….. IP Indian Journal of Clinical and Experimental Dermatology, April-June, 2018;4(2):123-131 131
24. Frenk E. Treatment of melasma with depigmenting agents; In: Melasma: New Approaches to Treatment; London: Martin Dunitz Ltd.;1995:9-15.
25. Van Scott E, Ditre CM, Yu RJ,; Alpha hydroxyl acids in the treatment of signs of photoageing ; Clin Dermatol 1996 ; 14:27-226.
26. Grover C, Reddu B S; The therapeutic value of glycolic acid peels in dermatology; Indian J Dermatol Venereol Leprol 2003;69:148-50.
27. Berardesca E, Distante F, Vignoli GP et al; Alpha hydroxy acids modulate stratum comeum barderfunction; Br J Dermatol 1997;137:934938.
28. Amer M, Metwalli M ; Topical hydroquinone in the treatment of some hyperpigmentary disorders; Int J Dermatol 1998;37:449-50.
29. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D; Jr; A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma; Int J Dermatol 2003;42:153-6.
30. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, ; Efficacy and safety of a new triple-combination agent for the treatment of facial melasma; Cutis 2003;72:67-72
31. Neering H; Treatment of melasma (chloasma) by local application of a steroid cream; Dermatologica 1975;151:349-53.
32. Kanwar AJ, Dhar S, Kaur S; Treatment of melasma with potent topical corticosteroids; Dermatology 1994;188:170.
33. Kligman AM, Willis I; A new formula for depigmenting human skin; Arch Dermatol 1975;111:40-8.
34. Dhar S, Dutta P, Malakar R; Pigmentary disorders. In: Valia RG, Valia AR, editors. IADVL textbook of dermatology 3rd ed, Mumbai, India: Bhalani publishing house; 2008 736-98.
35. Griffiths CEM, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ; Topical tretinoin (retinoic acid) improves melasma; A vehicle controlled, clinical trial; Br J Dermatol 1993;129:415-21.
36. Torok H; A large 12-month extension study of triple ombination cream in melasma pateints previously treated with triple combination cream or one of its dysadvantages; J Drugs Dermatol 2005;4:592-7.
37. Sarkar R, Kaur C, Bhalla M, Kanwar AJ; The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: A comparative study; Dermatol Surg. 2002;28:828–32.
38. Lim JT, Tham SN; Glycolic acid peels in the treatment of melasma among Asian women; Dermatol Surg 1997;23:177–9.